Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.

This study is recruiting in Norway. It focuses on ADHD.
Leave your email and HopeStage can help you better understand this study.
This observational study is looking at how MinADHD works for people with Adhd, ADHD - Combined Type, ADHD Predominantly Inattentive Type, or ADHD, Predominantly Hyperactive - Impulsive in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment. Taking part may give some people access to MinADHD with regular follow-up, but direct benefit is not guaranteed.
The official record suggests a mix of remote and in-person participation through a lab, with sites including Bjørgvin DPS in Bergen. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis and having access to the required digital tools, while common reasons not to take part include active substance or alcohol problems that could affect the results and other treatments that could interfere with the study. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it adds public evidence around adhd. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
Taking part may help improve understanding of your condition.
It requires regular follow-up, often through questionnaires or interviews.
Mixes in-person and remote participation.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring digital app or tool for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Haukeland University Hospital. Based on the sponsor name or official registry information, it appears to be a hospital or academic medical center. You should verify the details in the official registry record.
This study may involve digital app or tool, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me